216 related articles for article (PubMed ID: 6142817)
1. [So-called pernicious catatonia].
Gabris G; Müller C
Encephale; 1983; 9(4):365-85. PubMed ID: 6142817
[TBL] [Abstract][Full Text] [Related]
2. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
3. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
Topka H; Buchkremer G
Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
[TBL] [Abstract][Full Text] [Related]
4. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
[TBL] [Abstract][Full Text] [Related]
5. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
Schulte-Sasse U; Komar K; Eberlein HJ
Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
[TBL] [Abstract][Full Text] [Related]
6. [Catatonia: resurgence of a concept. A review of the international literature].
Pommepuy N; Januel D
Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
[TBL] [Abstract][Full Text] [Related]
7. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
Weinberger DR; Kelly MJ
J Nerv Ment Dis; 1977 Oct; 165(4):263-8. PubMed ID: 908924
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors for neuroleptic malignant syndrome.
Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-associated catatonic reaction.
Dorevitch A; Gabbay F
Clin Pharm; 1983; 2(6):581-2. PubMed ID: 6140097
[No Abstract] [Full Text] [Related]
10. Detection and management of the neuroleptic malignant syndrome.
Bond WS
Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic catatonia and its relationship to psychogenic catatonia.
Fricchione GL
Biol Psychiatry; 1985 Mar; 20(3):304-13. PubMed ID: 2858225
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase.
Ungvari GS; Leung SK; Ng FS; Cheung HK; Leung T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):27-38. PubMed ID: 15610942
[TBL] [Abstract][Full Text] [Related]
13. Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings.
Blumer D
Compr Psychiatry; 1997; 38(4):193-201. PubMed ID: 9202876
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Stoudemire A; Luther JS
Int J Psychiatry Med; 1984; 14(1):57-63. PubMed ID: 6145675
[TBL] [Abstract][Full Text] [Related]
15. [Acute and subacute catatonic syndromes with weight loss. Its favorable development with electroconvulsive therapy].
Monchablon Espinoza AJ
Acta Psiquiatr Psicol Am Lat; 1991 Mar; 37(1):65-71. PubMed ID: 1862719
[TBL] [Abstract][Full Text] [Related]
16. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
Vancaester E; Santens P
Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
[TBL] [Abstract][Full Text] [Related]
17. Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study.
Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):463-7. PubMed ID: 21220791
[TBL] [Abstract][Full Text] [Related]
18. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic-induced catatonia: case report.
Johnson GC; Manning DE
J Clin Psychiatry; 1983 Aug; 44(8):310-2. PubMed ID: 6874654
[TBL] [Abstract][Full Text] [Related]
20. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
